4.7 Article

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

Aurelien Amiot et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Article Gastroenterology & Hepatology

Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab

Annick Moens et al.

JOURNAL OF CROHNS & COLITIS (2019)

Article Gastroenterology & Hepatology

Exposure to Vedolizumab in IBD Pregnant Women Appears of Low Risk for Mother and Neonate: A First Prospective Comparison Study

Ariella Bar-Gil Shitrit et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

Letter Gastroenterology & Hepatology

Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease-authors' reply

U. Mahadevan et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Letter Gastroenterology & Hepatology

Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease

M. Julsgaard et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Article Gastroenterology & Hepatology

Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines

Dawn B. Beaulieu et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Anti-TNF Levels in Cord Blood at Birth are Associated with Anti-TNF Type

Shannon L. Kanis et al.

JOURNAL OF CROHNS & COLITIS (2018)

Article Gastroenterology & Hepatology

Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry

Maria Chaparro et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Letter Gastroenterology & Hepatology

Letter: vedolizumab drug concentrations in neonates following intrauterine exposure

Emma Flanagan et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Letter Gastroenterology & Hepatology

Vedolizumab safety in pregnancy and newborn outcomes

Mette Julsgaard et al.

Review Gastroenterology & Hepatology

Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease

W. A. Bye et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

Article Gastroenterology & Hepatology

Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease

U. Mahadevan et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

Article Gastroenterology & Hepatology

Preconception Care Reduces Relapse of Inflammatory Bowel Disease During Pregnancy

Alison de Lima et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

Mette Julsgaard et al.

GASTROENTEROLOGY (2016)

Review Gastroenterology & Hepatology

Managing inflammatory bowel disease in pregnancy: current perspectives

Matthew Pinder et al.

CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2016)

Article Multidisciplinary Sciences

Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes

Heather A. Boyd et al.

PLOS ONE (2015)

Article Gastroenterology & Hepatology

The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease

C. J. van der Woude et al.

JOURNAL OF CROHNS & COLITIS (2015)

Article Gastroenterology & Hepatology

Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease

M. Seirafi et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)